Brandywine Global Investment Management LLC Sells 10,755 Shares of Cardinal Health, Inc. (NYSE:CAH)

Brandywine Global Investment Management LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 147,583 shares of the company's stock after selling 10,755 shares during the quarter. Brandywine Global Investment Management LLC owned about 0.06% of Cardinal Health worth $17,455,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Cyrus J. Lawrence LLC acquired a new stake in Cardinal Health during the fourth quarter worth approximately $26,000. Promus Capital LLC bought a new position in Cardinal Health during the fourth quarter worth $30,000. Lee Danner & Bass Inc. acquired a new position in Cardinal Health in the fourth quarter valued at $35,000. Kentucky Trust Co bought a new stake in Cardinal Health during the fourth quarter valued at $41,000. Finally, HHM Wealth Advisors LLC grew its holdings in Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after acquiring an additional 144 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CAH shares. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a report on Tuesday, January 7th. Mizuho upped their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a report on Friday, January 31st. Finally, Wells Fargo & Company upped their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $140.14.

Remove Ads

Cardinal Health Stock Performance

Shares of CAH traded down $3.68 on Friday, hitting $133.41. 938,832 shares of the stock traded hands, compared to its average volume of 2,116,226. The business has a 50 day simple moving average of $129.14 and a 200 day simple moving average of $121.44. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $139.50. The company has a market capitalization of $32.23 billion, a PE ratio of 24.92, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.